![]() |
Volumn 60, Issue 3, 2007, Pages 464-469
|
Meeting report: Fourth forum on respiratory tract infections, sitges, spain, 8-11 February 2007
|
Author keywords
Antibiotic resistance conservation; Avian influenza; Disease definitions and management; New antibiotics; Outcome assessments
|
Indexed keywords
ANTIBIOTIC AGENT;
BETA LACTAM ANTIBIOTIC;
CEFTOBIPROLE;
CEPHALOSPORIN;
CLINDAMYCIN;
DALBAVANCIN;
DALFOPRISTIN PLUS QUINUPRISTIN;
DORIPENEM;
FOSFOMYCIN;
FUSIDIC ACID;
GLYCOPEPTIDE;
IMIPENEM;
INFLUENZA VACCINE;
LEVOFLOXACIN;
LINEZOLID;
MACROLIDE;
MOXIFLOXACIN;
ORITAVANCIN;
OSELTAMIVIR;
PNEUMOCOCCUS VACCINE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFAMPICIN;
SIALIDASE INHIBITOR;
TELAVANCIN;
TETRACYCLINE DERIVATIVE;
TIGECYCLINE;
TROVAFLOXACIN;
UNINDEXED DRUG;
VANCOMYCIN;
ZANAMIVIR;
ABDOMINAL INFECTION;
ANTIBIOTIC RESISTANCE;
AVIAN INFLUENZA;
BACTERIAL PNEUMONIA;
BLOOD TOXICITY;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
COMMUNITY ACQUIRED PNEUMONIA;
CONFERENCE PAPER;
DISEASE EXACERBATION;
DRUG MEGADOSE;
DRUG PENETRATION;
DRUG TREATMENT FAILURE;
EPIDEMIC;
EVIDENCE BASED MEDICINE;
GRAM POSITIVE BACTERIUM;
HOSPITAL INFECTION;
HUMAN;
INFECTION CONTROL;
INTENSIVE CARE UNIT;
MEDICAL EDUCATION;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MINIMUM INHIBITORY CONCENTRATION;
MONOTHERAPY;
NEUROTOXICITY;
NONHUMAN;
OUTCOME ASSESSMENT;
PHARMACODYNAMICS;
PRACTICE GUIDELINE;
RESPIRATORY TRACT INFECTION;
RISK FACTOR;
STREPTOCOCCUS PNEUMONIAE;
VENTILATOR ASSOCIATED PNEUMONIA;
ANIMALS;
ANTI-BACTERIAL AGENTS;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
RESPIRATORY TRACT INFECTIONS;
|
EID: 34548133686
PISSN: 03057453
EISSN: 14602091
Source Type: Journal
DOI: 10.1093/jac/dkm216 Document Type: Conference Paper |
Times cited : (4)
|
References (0)
|